Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17022393 | 0.98 | MEN1 (0.46) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL20913712 | 0.98 | MEN1 (0.46) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL13893120 | 0.85 | CA1 (0.40) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL16638629 | 0.85 | TSHR (0.42) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL7720634 | 0.84 | LTA4H (0.36) | TSHRMEN1KMT2ALTA4HSMN1; SMN2 | |
| SCHEMBL2607368 | 0.81 | KDM4E (0.40) | MEN1KMT2AALDH1A1KDM4ELTA4H | |
| SCHEMBL7716541 | 0.81 | TSHR (0.47) | TSHRKMT2AALDH1A1LTA4HCAMK2A | |
| SCHEMBL28698203 | 0.81 | MAOA (0.35) | TSHRMEN1KMT2AALDH1A1LTA4H | |
| SCHEMBL8333250 | 0.81 | MAOA (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL7220626 | 0.80 | EPHX2 (0.39) | TSHRLTA4HCA1CA2EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | X-THERMA, INC. (US) | 2023-09-21 | — | — | US | disclosed |
| EP-2495246-A1 | FULLERENE DERIVATIVE | Sumitomo Chemical Company, Limited (JP) | 2012-09-05 | — | — | EP | disclosed |
| EP-2448033-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Sumitomo Chemical Company, Limited (JP) | 2012-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292741-A1 | NOVEL SUPERCOOLING METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | PPIG, AQP3, AQP1 | TSHR 4596/4885MAPK1 4332/4885MEN1 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.